SavedAdd your journal

Journals / Türk Osteoporoz Dergisi / 2016 / Cilt: 22 - Sayı: 2

Idiopathic Thrombocytopenic Purpura as Initial Manifestation of Systemic Lupus Erythematosus: A Case Report

İdiyopatik Trombositopenik Purpura ile Prezente Olan Sistemik Lupus Eritematozus Olgusu: Bir Olgu Sunumu

Akın ERDAL
Fatih BAĞCIER
Pages
110–112
Publication Date
2022-11-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, patients may present rare types of manifestations such as idiopathic thrombocytopenic purpura.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can affect almost any organ system.
📊
Key Findings & Data:Its presentation and course are highly variable.
💡
Conclusion & Impact:However, patients may present rare types of manifestations such as idiopathic thrombocytopenic purpura.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can affect almost any organ system. Its presentation and course are highly variable. The classic presentation of SLE in a woman of childbearing age is fever, arthritis, and malar rash triad. However, patients may present rare types of manifestations such as idiopathic thrombocytopenic purpura.

Özet

Sistemik lupus eritematozus, hemen hemen bütün organları etkileyebilen kronik otoimmün bir hastalıktır. Hastalık çok farklı kliniklerle prezante olabilir. Klasik olarak başlangıç, doğurganlık çağındaki kadınlarda ateş, artrit, malar raş triatı şeklindedir. Ancak nadir olarak idiyopatik trombositopenik purpura gibi farklı kliniklerle prezantasyon görülebilir.

🔖

Cite This Article

ERDAL, A., BAĞCIER, F. (2022). Idiopathic Thrombocytopenic Purpura as Initial Manifestation of Systemic Lupus Erythematosus: A Case Report. Türk Osteoporoz Dergisi, Cilt: 22 - Sayı: 2, 110–112. https://ajindex.com/articles/639743

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Chandrasekaran AN, Rajendran CP, Ramakrishnan S, Madhavan R, Parthiban M. Childhood systemic lupus erythematosus in south India. Indian J Pediatr 1994;61:223-9.
  2. Boddaert J, Huong DL, Amoura Z, Wechsler B, Godeau P, Piette JC. Late-onset systemic lupus erythematosus: a personal series of 47 patients and pooled analysis of 714 cases in the literature. Medicine (Baltimore) 2004;83:348-59.
  3. Nesher G, Hanna VE, Moore TL, Hers M, Osborn TG. Thrombotic microangiographic hemolytic anemia in systemic lupus erythematosus. Semin Arth Rheum 1994;24:165-72.
  4. Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010;115:168-86.
  5. Ziakas PD, Giannouli S, Zintzaras E, Tzioufas AG, Voulgarelis M. Lupus thrombocytopenia: clinical implications and prognostic significance. Ann Rheum Dis 2005;64:1366-9.
  6. Blanchette V, Freedman J, Garvey B. Management of chronic immune thrombocytopenic purpura in children and adults. Semin Hematol 1998;35(Suppl 1):36-51.
  7. Ruggeri M, Fortuna S, Rodeghiero F. Heterogeneity of terminology and clinical definitions in adult idiopathic thrombocytopenic purpura: a critical appraisal from a systematic review of the literature. Haematologica 2008;93:98-103.
  8. Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010;115:168-86. Looney RJ. B cell-targeted therapy in diseases other than rheumatoid arthritis. J Rheumatol Suppl 2005;73:25-8.